查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941542

臨床前影像市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測（2026-2033 年）

Preclinical Imaging Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床前影像市場概述

全球臨床前影像市場規模預計到 2025 年將達到 10.5 億美元，到 2033 年將達到 16.3 億美元。

預計從 2026 年到 2033 年，該行業將以 5.6% 的複合年成長率成長。這一成長是由慢性病患病率上升、藥物研發投資增加以及對非侵入性成像技術的需求增加所驅動的。

早期研究中先進影像技術的應用，以及轉化研究工作的不斷深入，進一步推動了市場擴張。

政府主導的各項舉措，包括來自美國國立衛生研究院 (NIH) 以及歐洲和亞洲類似機構的津貼和資助，顯著加強了臨床前研究，並支持了臨床前影像市場。例如，2022 年 9 月，NIH 和美國衛生與公眾服務部 (DHHS) 發布了針對產腸毒素大腸桿菌 (ETEC)、甲型副傷寒沙門氏菌和志賀氏菌屬的里程碑式臨床前疫苗開發提案徵集。

該計畫將在五年內每年提供高達75萬美元的資金，用於支持疫苗最佳化、規模化生產、安全性和有效性測試，以及推進候選疫苗進入臨床試驗階段。符合資格的申請對象包括學術機構、非營利組織、政府機構和企業。美國國家過敏症和感染疾病研究所 (NIAID) 將資助四到六個計劃，總計520萬美元，以加速候選疫苗向美國食品藥物管理局 (FDA)津貼臨床實驗(IND) 申請。這筆資金將使研究人員能夠投資於先進平台、開發新型探針並擴展縱向研究，從而滿足臨床前體內成像市場日益成長的需求，並促進光學臨床前成像等領域的發展。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 臨床前影像市場變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 臨床前影像市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 臨床前影像市場：按類型分類的估計和趨勢分析

  • 全球臨床前影像：按類型分類的市場波動分析
  • 全球臨床前影像市場規模及趨勢分析（按類型分類）（2021-2033 年）
  • 模態
    • 光學成像（BLI 和 F）
    • 磁振造影（MRI）
    • 正子斷層掃描（PET）
    • 單光子發射電腦斷層掃描（SPECT）
    • 電腦斷層掃描（CT）
    • 超音波影像（US）
    • 光聲成像（PAI）
    • 混合成像系統
    • 其他
  • 試劑
  • 服務

第5章 臨床前影像市場：按應用分類的估算與趨勢分析

  • 全球臨床前影像：按應用分類的市場趨勢分析
  • 全球臨床前影像市場規模及應用趨勢分析（2021-2033）
  • 藥物發現與開發
  • 毒理學和藥物動力學研究
  • 基礎研究與轉化研究
  • 疾病機轉與病理學研究
    • 腫瘤學
    • 心臟病學
    • 神經病學
    • 感染疾病
    • 免疫學/炎症
    • 其他
  • 生物標記和診斷成像劑的檢驗
  • 其他

第6章：臨床前影像市場：依最終用途分類的估算與趨勢分析

  • 全球臨床前成像：按最終用途分類的市場趨勢分析
  • 全球臨床前影像市場規模及應用趨勢分析（2021-2033）
  • 製藥和生物技術公司
  • 受託研究機構（CRO）
  • 學術研究機構
  • 其他

7. 臨床前影像市場：區域估算和趨勢分析（按類型、應用和最終用途分類）

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 市場規模及預測趨勢分析（2021-2033）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
  • 主要企業市佔率分析（2025 年）
  • 公司地位分析
  • 公司分類（新興企業、創新者、領導企業）
  • 公司簡介
    • Cubresa Inc.
    • Bruker Corporation
    • Revvity（PerkinElmer, Inc）
    • FUJIFILM VisualSonics
    • Mediso Ltd.
    • Rigaku（MILabs BV）
    • MR Solutions
    • Aspect Imaging
    • TriFoil Imaging
    • Siemens Healthineers
Product Code: 978-1-68038-881-7

Preclinical Imaging Market Summary

The global preclinical imaging market size was valued at USD 1.05 billion in 2025 and is expected to reach USD 1.63 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, increasing investments in drug development, and growing demand for non-invasive imaging techniques.

The adoption of advanced imaging modalities for early-stage research, coupled with the expansion of translational research initiatives, further accelerates market expansion.

Government initiatives, including grants and funding from organizations such as the National Institutes of Health (NIH) and similar agencies in Europe and Asia, are significantly enhancing preclinical research and bolstering the preclinical imaging market. For example, in September 2022, the NIH and the U.S. Department of Health and Human Services (DHHS) called for applications for milestone-driven preclinical vaccine development targeting Enterotoxigenic Escherichia coli (ETEC), Salmonella Paratyphi A, and Shigella species.

The program supported vaccine optimization, scale-up, safety, and efficacy testing, offering up to USD 750,000 annually over five years to help candidates reach clinical readiness. Eligible applicants included academic institutions, nonprofits, governments, and businesses. The National Institute of Allergy and Infectious Diseases (NIAID) planned to award USD 5.2 million across 4-6 projects to advance candidates toward FDA IND submission. This influx of funding allows researchers to invest in advanced platforms, develop new probes, and expand longitudinal studies, increasing demand in the preclinical in-vivo imaging market and supporting growth in segments like optical preclinical imaging.

Global Preclinical Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical imaging market based on type, application, end use and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Modality
    • Optical Imaging (BLI & F)
    • Magnetic Resonance Imaging (MRI)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Computed Tomography (CT)
    • Ultrasound Imaging (US)
    • Photoacoustic Imaging (PAI)
    • Hybrid Imaging Systems
    • Bi-Modal
    • SPECT-CT
    • PET-CT
    • SPECT-PET
    • PET-MRI
    • Optical-CT
    • Others
    • Tri-Modal
    • PET-SPECT-CT
    • PET-SPECT-MRI
    • PET-CT-Optical
    • Others
    • Others
  • Reagent
  • Service
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Toxicology & Pharmacokinetics Studies
  • Basic & Translational Research
  • Disease Mechanism & Pathophysiology Studies
    • Oncology
    • Cardiology
    • Neurology
    • Infectious Diseases
    • Immunology & Inflammation
    • Others
  • Biomarker & Imaging Agent Validation
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Preclinical Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Preclinical Imaging Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical Imaging Type Market Movement Analysis
  • 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Modality
    • 4.4.1. Modality market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Optical Imaging (BLI & F)
      • 4.4.2.1. Optical Imaging (BLI & F) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Magnetic Resonance Imaging (MRI)
      • 4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Positron Emission Tomography (PET)
      • 4.4.4.1. Positron Emission Tomography (PET) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Single Photon Emission Computed Tomography (SPECT)
      • 4.4.5.1. Single Photon Emission Computed Tomography (SPECT) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.6. Computed Tomography (CT)
      • 4.4.6.1. Computed Tomography (CT) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.7. Ultrasound Imaging (US)
      • 4.4.7.1. Ultrasound Imaging (US) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.8. Photoacoustic Imaging (PAI)
      • 4.4.8.1. Photoacoustic Imaging (PAI) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.9. Hybrid Imaging Systems
      • 4.4.9.1. Hybrid Imaging Systems market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2. Bi-Modal
        • 4.4.9.2.1. Bi-Modal market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.2. SPECT-CT
          • 4.4.9.2.2.1. SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.3. PET-CT
          • 4.4.9.2.3.1. PET-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.4. SPECT-PET
          • 4.4.9.2.4.1. SPECT-PET market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.5. PET-MRI
          • 4.4.9.2.5.1. PET-MRI market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.6. Optical-CT
          • 4.4.9.2.6.1. Optical-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.7. Others
          • 4.4.9.2.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3. Tri-Modal
        • 4.4.9.3.1. Tri-Modal market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.2. PET-SPECT-CT
          • 4.4.9.3.2.1. PET-SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.3. PET-SPECT-MRI
          • 4.4.9.3.3.1. PET-SPECT-MRI market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.4. PET-CT-Optical
          • 4.4.9.3.4.1. PET-CT-Optical market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.5. Others
          • 4.4.9.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.10. Others
      • 4.4.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Reagent
    • 4.5.1. Reagent market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Preclinical Imaging Application Market Movement Analysis
  • 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Drug Discovery & Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Toxicology & Pharmacokinetics Studies
    • 5.5.1. Toxicology & Pharmacokinetics Studies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Basic & Translational Research
    • 5.6.1. Basic & Translational Research market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Disease Mechanism & Pathophysiology Studies
    • 5.7.1. Disease Mechanism & Pathophysiology Studies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.2. Oncology
      • 5.7.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.3. Cardiology
      • 5.7.3.1. Cardiology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.4. Neurology
      • 5.7.4.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.5. Infectious Diseases
      • 5.7.5.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.6. Immunology & Inflammation
      • 5.7.6.1. Immunology & Inflammation market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.7. Others
      • 5.7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Biomarker & Imaging Agent Validation
    • 5.8.1. Biomarker & Imaging Agent Validation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Preclinical Imaging End Use Market Movement Analysis
  • 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharma and Biotech Companies
    • 6.4.1. Pharma and biotech companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Contract Research Organizations (CROs)
    • 6.5.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Academic and Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Type, Application, End Use

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2025
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 8.6. Company Profiles
    • 8.6.1. Cubresa Inc.
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Bruker Corporation
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Revvity (PerkinElmer, Inc)
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. FUJIFILM VisualSonics
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Mediso Ltd.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Rigaku (MILabs B.V.)
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. MR Solutions
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Aspect Imaging
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. TriFoil Imaging
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. Siemens Healthineers
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 3 North America preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 4 North America preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 5 North America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 7 U.S. preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 8 U.S. preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 9 Canada preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 10 Canada preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 11 Canada preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 13 Mexico preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 14 Mexico preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 15 Europe preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 16 Europe preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 17 Europe preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 18 Europe preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 19 UK preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 20 UK preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 21 UK preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 22 Germany preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 23 Germany preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 24 Germany preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 25 France preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 26 France preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 27 France preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 28 Italy preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 29 Italy preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 30 Italy preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 31 Denmark preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 32 Denmark preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 33 Denmark preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 34 Sweden preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 35 Sweden preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 36 Sweden preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 37 Norway preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 38 Norway preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 39 Norway preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 40 Asia Pacific preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 44 Japan preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 45 Japan preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 46 Japan preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 47 China preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 48 China preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 49 China preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 50 India preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 51 India preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 52 India preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 53 Australia preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 54 Australia preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 55 Australia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 57 South Korea preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 58 South Korea preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 59 Thailand preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 60 Thailand preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 61 Thailand preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 62 Latin America preclinical imaging market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Latin America preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 64 Latin America preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 65 Latin America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 66 Brazil preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 67 Brazil preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 68 Brazil preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 69 Argentina preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 70 Argentina preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 71 Argentina preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 72 Middle East & Africa preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 73 Middle East & Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 74 Middle East & Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 76 South Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 77 South Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 78 South Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 79 Saudi Arabia preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 80 Saudi Arabia preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 81 Saudi Arabia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 82 UAE preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 83 UAE preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 84 UAE preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 85 Kuwait preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 86 Kuwait preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 87 Kuwait preclinical imaging market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Preclinical imaging market: Market outlook
  • Fig. 14 Preclinical imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Preclinical imaging market driver impact
  • Fig. 20 Preclinical imaging restraint impact
  • Fig. 21 Preclinical imaging market: type movement analysis
  • Fig. 22 Preclinical imaging market: type outlook and key takeaways
  • Fig. 23 Modality market estimates and forecast, 2021 - 2033
  • Fig. 24 Optical Imaging (BLI & F) market estimates and forecast, 2021 - 2033
  • Fig. 25 MRI market estimates and forecast, 2021 - 2033
  • Fig. 26 PET market estimates and forecast, 2021 - 2033
  • Fig. 27 SPECT market estimates and forecast, 2021 - 2033
  • Fig. 28 CT market estimates and forecast, 2021 - 2033
  • Fig. 29 Ultrasound Imaging (US) market estimates and forecast, 2021 - 2033
  • Fig. 30 Photoacoustic Imaging (PAI) market estimates and forecast, 2021 - 2033
  • Fig. 31 Hybrid Imaging Systems market estimates and forecast, 2021 - 2033
  • Fig. 32 Bi-Modal market estimates and forecast, 2021 - 2033
  • Fig. 33 SPECT-CT market estimates and forecast, 2021 - 2033
  • Fig. 34 PET-CT market estimates and forecast, 2021 - 2033
  • Fig. 35 SPECT-PET market estimates and forecast, 2021 - 2033
  • Fig. 36 PET-MRI market estimates and forecast, 2021 - 2033
  • Fig. 37 Optical-CT market estimates and forecast, 2021 - 2033
  • Fig. 38 Others market estimates and forecast, 2021 - 2033
  • Fig. 39 Tri-Modal market estimates and forecast, 2021 - 2033
  • Fig. 40 PET-SPECT-CT market estimates and forecast, 2021 - 2033
  • Fig. 41 PET-SPECT-MRI market estimates and forecast, 2021 - 2033
  • Fig. 42 PET-CT-Optical market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecast, 2021 - 2033
  • Fig. 44 Reagents market estimates and forecast, 2021 - 2033
  • Fig. 45 Services market estimates and forecast, 2021 - 2033
  • Fig. 46 Preclinical imaging market: application movement analysis
  • Fig. 47 Preclinical imaging market: application outlook and key takeaways
  • Fig. 48 Drug Discovery & Development market estimates and forecast, 2021 - 2033
  • Fig. 49 Toxicology & Pharmacokinetics Studies market estimates and forecast, 2021 - 2033
  • Fig. 50 Basic & Translational Research market estimates and forecast, 2021 - 2033
  • Fig. 51 Disease Mechanism & Pathophysiology Studies market estimates and forecast, 2021 - 2033
  • Fig. 52 Oncology market estimates and forecast, 2021 - 2033
  • Fig. 53 Cardiology market estimates and forecast, 2021 - 2033
  • Fig. 54 Neurology market estimates and forecast, 2021 - 2033
  • Fig. 55 Infectious Diseases market estimates and forecast, 2021 - 2033
  • Fig. 56 Immunology & Inflammation market estimates and forecast, 2021 - 2033
  • Fig. 57 Others market estimates and forecast, 2021 - 2033
  • Fig. 58 Biomarker & Imaging Agent Validation market estimates and forecast, 2021 - 2033
  • Fig. 59 Others market estimates and forecast, 2021 - 2033
  • Fig. 60 Preclinical imaging market: end use movement analysis
  • Fig. 61 Preclinical imaging market: end use outlook and key takeaways
  • Fig. 62 Pharma and biotech companies market estimates and forecast, 2021 - 2033
  • Fig. 63 Contract Research Organizations (CROs) market estimates and forecast, 2021 - 2033
  • Fig. 64 Academic and Research Institutes market estimates and forecast, 2021 - 2033
  • Fig. 65 Others market estimates and forecast, 2021 - 2033
  • Fig. 66 Global Preclinical Imaging Market: regional movement analysis
  • Fig. 67 Global Preclinical Imaging Market: regional outlook and key takeaways
  • Fig. 68 North America
  • Fig. 69 North America market estimates and forecast, 2021 - 2033
  • Fig. 70 U.S.
  • Fig. 71 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 72 Canada
  • Fig. 73 Canada market estimates and forecast, 2021 - 2033
  • Fig. 74 Mexico
  • Fig. 75 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 76 Europe
  • Fig. 77 Europe. market estimates and forecast, 2021 - 2033
  • Fig. 78 UK
  • Fig. 79 UK market estimates and forecast, 2021 - 2033
  • Fig. 80 Germany
  • Fig. 81 Germany market estimates and forecast, 2021 - 2033
  • Fig. 82 France
  • Fig. 83 France market estimates and forecast, 2021 - 2033
  • Fig. 84 Italy
  • Fig. 85 Italy market estimates and forecast, 2021 - 2033
  • Fig. 86 Spain
  • Fig. 87 Spain market estimates and forecast, 2021 - 2033
  • Fig. 88 Denmark
  • Fig. 89 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 90 Sweden
  • Fig. 91 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 92 Norway
  • Fig. 93 Norway market estimates and forecast, 2021 - 2033
  • Fig. 94 Asia Pacific
  • Fig. 95 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 96 Japan
  • Fig. 97 Japan market estimates and forecast, 2021 - 2033
  • Fig. 98 China
  • Fig. 99 China market estimates and forecast, 2021 - 2033
  • Fig. 100 India
  • Fig. 101 India market estimates and forecast, 2021 - 2033
  • Fig. 102 South Korea
  • Fig. 103 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 104 Thailand
  • Fig. 105 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 106 Australia
  • Fig. 107 Australia market estimates and forecast, 2021 - 2033
  • Fig. 108 Latin America
  • Fig. 109 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 110 Brazil
  • Fig. 111 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 112 Argentina
  • Fig. 113 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 114 Middle East and Africa
  • Fig. 115 Middle East and Africa. market estimates and forecast, 2021 - 2033
  • Fig. 116 Saudi Arabia
  • Fig. 117 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 118 South Africa
  • Fig. 119 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 120 UAE
  • Fig. 121 UAE market estimates and forecast, 2021 - 2033
  • Fig. 122 Kuwait
  • Fig. 123 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 124 Participant categorization- Preclinical imaging market
  • Fig. 125 Market share of key market players- Preclinical imaging market